Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID‐19 Infection
Immunity, Inflammation and Disease · 2025
DOI: 10.1002/iid3.70137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Zhiyong Hou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences (CI2023C063YLL) and National Major….
Abstract (Originalsprache)
Background
Long COVID, a heterogeneous condition characterized by a range of physical and neuropsychiatric presentations, can be presented with a proportion of COVID‐19‐infected individuals.
Methods
Transcriptomic data sets of those within gene expression profiles of COVID‐19, long COVID, and healthy controls were retrieved from the GEO database. Differentially expressed genes (DEGs) falling under COVID‐19 and long COVID were identified with R packages, and contemporaneously conducted module detection was performed with the Modular Pharmacology Platform ( http://112.86.129.72:48081/ ). The integration of both DEGs and differentially expressed module‐genes (DEMGs) regarding long COVID and COVID‐19 was intersected by following Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA).
Results
There were 11 and 62 differentially expressed modules, 1837 and 179 DEGs, as well as 103 and 508 DEMGs acquiring identified for both COVID‐19 and long COVID, notably enriched in the immune‐correlated signaling pathways. The immune infiltrating cells of long COVID and COVID‐19 were comparatively and respectively assessed via CIBERSORT, ssGSEA, and xCell algorithms. Subsequently, the screening of hub genes involved employing the SVM‐RFE, RF, XGBoost algorithms, and logistic regression analysis. Among the 67 candidate genes were processed with machine learning algorithms and logistic regression, a subgroup consisting of CEP55, CDCA2, MELK, and DEPDC1B, was at last identified as potential biomarkers for predicting the risk of the progression into long COVID after COVID‐19 infections. The predicting performance of the potential biomarkers was quantified with a ROC value of 0.8762542, which proved the combination of potential biomarkers provided the highest performance.
Conclusions
In summary, we identified a subgroup of potential biomarkers for predicting the risk of the progression into long COVID after COVID‐19 infection, which could be partly elucidation of the associated molecular mechanisms for long COVID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
ORCID-Profile: Zhiyong Hou
Förderung
- This study was supported by the Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences (CI2023C063YLL) and National Major…
Zitieren
APA
Hou, Z., Ming, Y., Liu, J., & Wang, Z. (2025). Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID‐19 Infection. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70137
Vancouver
Hou Z, Ming Y, Liu J, Wang Z. Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID‐19 Infection. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70137
BibTeX
@article{Hou2025,
author = {Hou, Zhiyong and Ming, Yu and Liu, Jun and Wang, Zhong},
title = {Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID‐19 Infection},
journal = {Immunity, Inflammation and Disease},
year = {2025},
doi = {10.1002/iid3.70137}
}
EUVIMED